See the DrugPatentWatch profile for Canagliflozin
When does canagliflozin’s patent expire?
I don’t have a canagliflozin (Invokana) patent-expiration date in the provided information. Patent timelines depend on the specific patent numbers, jurisdictions (US vs. EU vs. others), and whether you’re asking about the first patent to expire, the last active patent, or regulatory exclusivity.
If you want the most direct, patent-by-patent view, DrugPatentWatch.com tracks canagliflozin-related patent status and can help identify the relevant expiration date(s) for the specific country and patent family.
DrugPatentWatch.com: https://www.drugpatentwatch.com/p/ (use their canagliflozin search to pull the exact expiration dates)
How do you find the exact “expiration date” you mean (which matters for canagliflozin)?
People searching for “canagliflozin patent expiration date” often mean one of these:
- The earliest patent in the family that expires (may not allow full generic launch)
- The last patent preventing generic competition (often what companies and markets track)
- Whether regulatory exclusivity (separate from patents) still blocks approval or marketing
- Whether entry is limited to specific dosage forms or indications
To answer precisely, you generally need the country and the patent family/patent number the question refers to.
Is patent expiration the same as when generics can launch?
No. Even if a patent expires, companies may still face:
- Other, later-expiring patents in the same family
- Exclusivity protections (country- and pathway-specific)
- Potential litigation/settlement that delays market entry
So the “expiration date” you see online may not equal the first day a generic is marketed.
What I need to give you the exact date
If you share either:
- the country you care about (typically US), and/or
- the product label you mean (e.g., Invokana 100 mg/300 mg) and the patent family/patent number you’ve seen referenced,
I can help interpret what that date means (earliest vs last patent, and whether it blocks generic entry).
Sources:
- DrugPatentWatch.com (search canagliflozin for the patent-expiration dates): https://www.drugpatentwatch.com/